NEW YORK — In a presentation at OSN New York Retina, Avni P. Finn, MD, MBA, discusses when to treat patients for central serous retinopathy as well as the most effective treatments.
Finn uses topline data to evaluate the efficacy of different CSCR treatment options, including mineralocorticoid antagonists, laser photocoagulation, photodynamic therapy and subthreshold micropulse laser photocoagulation.